Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 05 December 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Latest impact factors for gastroenterology and hepatology journals

Interesting changes have been revealed from the latest gastroenterology and hepatology journal impact factors, for the year 2000.

News image

Gastroenterology is still the journal with the greatest impact factor, followed by Hepatology.

However, now in third place is Seminars in Liver Disease. This journal was 7th in 1999. Gut has therefore been displaced into 4th place.

Alimentary Pharmacology & Therapeutics is another improver - it has moved up to 6th place, from last year's position of 8th.

The impact factors are published by ISI. Their definition of an impact factor is "a measure of the frequency with which the 'average article' in a journal has been cited in a particular year or period."

The annual journal citation report impact factor is a ratio between citations and recent citable items published. Thus, the impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.

Journals with greatest impact:
1 Gastroenterology
2 Hepatology
3 Semin Liver Dis
4 Gut
5 J Hepatol
6 Aliment Pharmacol Ther
ISI

ISI explain that, "The impact factor is useful in clarifying the significance of absolute (or total) citation frequencies. It eliminates some of the bias of such counts, which favor large journals over small ones, or frequently issued journals over less frequently issued ones, and of older journals over newer ones. Particularly in the latter case such journals have a larger citable body of literature than smaller or younger journals.

"All things being equal, the larger the number of previously published articles, the more often a journal will be cited."

Here is the "Top Forty Four" of the impact factors for 2000:

Journal    Impact factor
Gastroenterology    12.246
Hepatology    7.304
Semin Liver Dis    6.012
Gut    5.386
J Hepatol    3.761
Aliment Pharmacol Ther    3.489
Am J Physiol-Gastr L    3.115
Am J Gastroenterol    2.834
Gastrointest Endosc    2.820
Helicobacter    2.639
J Viral Hepat    2.157
Liver Transplant    2.130
Neurogastroenterol Motil    2.081
Scand J Gastroenterol    1.842
Endoscopy    1.817
Hepatol Res    1.808
Inflamm Bowel Dis    1.791
Digestion    1.780
Gastroenterol Clin North Am    1.774
Liver    1.739
Bailliere Clin Gastr    1.733
Int J Colorectal Dis    1.707
Dis Colon Rectum    1.690
Can J Gastroenterol    1.645
J Pediatr Gastroenterol Nutr    1.580
Dig Dis Sci    1.498
Ital J Gastroenterol    1.289
Eur J Gastroenterol Hepatol    1.142
J Clin Gastroenterol    1.127
J Gastroenterol Hepatol    1.116
World J Gastroenterol    0.993
J Gastroenterol    0.990
Gastroen Clin Biol    0.927
Hepato-Gastroenterol    0.905
Z Gatsroenterol    0.887
Abdom Imaging    0.886
Dig Surg    0.810
Dig Dis    0.744
Acta Gastro-Ent Belg    0.605
Curr Opin Gastroen    0.577
Rev Esp Enferm Dig    0.384
J Diarrhoel Dis Res    0.379
Chir Gastroenterol    0.078
Best Pract Res Cl Ga    0.067

ISI
03 September 2001

Go to top of page Email this page Email this page to a colleague

 05 December 2016 
Reducing hospitalization in IBD
 05 December 2016 
Disease mangement in IBD
 05 December 2016 
New biomarkers for IBD diagnosis
 02 December 2016 
Hep E in acute liver failure
 02 December 2016 
Occurrence and severity of alcoholic hepatitis
 02 December 2016 
Food antigen in active eosinophilic esophagitis
 01 December 2016 
Iron deficiency in anemic ulcerative colitis patients
 01 December 2016 
Prognostic factors after paracetamol-induced liver failure
 01 December 2016 
Factors that influence colorectal cancer screening findings
 30 November 2016 
Certolizumab pegol in Crohn's disease
 30 November 2016 
Genetic risk of Crohn's in chronic granulomatous disease
 30 November 2016 
Rifaximin in diarrhea-predominant IBS
 29 November 2016 
Assessing liver steatosis
 29 November 2016 
Colorectal cancer surveillance in ulcerative colitis
 29 November 2016 
Treating Zenker's diverticulum
 28 November 2016 
Complications in celiac disease
 28 November 2016 
Monitoring IBD with mobile technology
 28 November 2016 
Reducing warfarin-related upper GI bleeds
 25 November 2016 
Metal vs plastic stents for pancreatic cancer surgery
 25 November 2016 
Yoga and IBS therapy 
 25 November 2016 
Colorectal cancer screening issues
 24 November 2016 
Partner burden in celiac disease
 24 November 2016 
Fusobacterium nucleatum for colorectal cancer prognosis
 24 November 2016 
PPIS and gastric cancer risk
 23 November 2016 
Diagnosing autoimmune pancreatitis
 23 November 2016 
Readmissions in cirrhosis
 23 November 2016 
Quality assurance standards for colonoscopy
 22 November 2016 
Fatigue in IBD
 22 November 2016 
PPIs and C. diff in ICU 
 22 November 2016 
Bile acid diarrhea in function bowel disorder with diarrhea
 21 November 2016 
Financial incentives and colorectal cancer screening
 21 November 2016 
Pain after endoscopic resection of gastric tumors
 21 November 2016 
Antivirals and chemotherapy in Hep C patients with cancer
 18 November 2016 
Ustekinumab in Crohn’s disease
 18 November 2016 
Colorectal cancer risk and self-reported family history
 18 November 2016 
Antivirals and chemotherapy in Hep C patients with cancer
 17 November 2016 
Liver-related specialty care in patients with Hep C
 17 November 2016 
Risk of overweight in infants
 17 November 2016 
Moderate alcohol consumption and NAFLD
 16 November 2016 
PPI therapy in liver disease
 16 November 2016 
Education in Gastroenterology fellowship
 16 November 2016 
Paternal preconceptional use of anti-TNF-α agents
 15 November 2016 
Novel treatment of NASH 
 15 November 2016 
Physician perspectives on Hep C management
 15 November 2016 
Contraceptives and ulcerative colitis
 14 November 2016 
Cardiovascular risk in NAFLD 
 14 November 2016 
Vit D and NAFLD
 14 November 2016 
Malignancy risk in IBD 
 11 November 2016 
Treatment of Hep C along with opioid agonist therapy
 11 November 2016 
Diabetes and liver cancer risk in Hep C cirrhosis
 11 November 2016 
Biomarker of cirrhosis progression
 10 November 2016 
Testosterone levels and cirrhosis outcomes in men
 10 November 2016 
Improving bowel quality before colonoscopy
 10 November 2016 
Fecal microbiota transplantation and CDI episodes
 09 November 2016 
Minimizing costs of esophagogastroduodenoscopy and colonoscopy
 09 November 2016 
Risk of TB in IBD patients receiving therapy
 09 November 2016 
Liver transplant wait-list and mortality in infants
 08 November 2016 
NSAIDS and risk of Barrett’s
 08 November 2016 
Ferritin levels and NAFLD mortality
 08 November 2016 
Alarms in the diagnosis of colorectal cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us